CYP2C19 and coronary artery disorder: This conclusion is consistent with that of a previous study (Li et al., 2018), and in addition to CYP2C19, N6AMT1 rs2254638 polymorphism also had an effect on clopidogrel resistance in Chinese patients with coronary heart disease.